BioSpace News Archive

SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy using SONALA-001 in combination with Insightec’s MR-guided focused ultrasound, has appointed Ely Benaim, M.D., as Chief Medical Officer and Executive Vice President of Development.

Culmination Bio today announced a partnership to leverage samples and data from one of the largest biobanks in the country to fuel the development of Cofactor Genomic’s OncoPrism™ test in 11 cancers.

Pfizer and Thermo Fisher Scientific Inc. (NYSE: TMO) today announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.

Cerevance today announced plans to present at the upcoming Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development conference, taking place in British Columbia, Canada, May 15 – 19, 2023.

Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today that based on the most recent scientific and clinical evidence, the ACR Committee on Drugs and Contrast Media has classified Elucirem™ (gadopiclenol) as a Group II agent.

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new long-term follow-up data from the Company’s ELPIS I trial of Lomecel-BTM for patients with hypoplastic left heart syndrome (HLHS).

SeqLL Inc. announced its operating and financial results for the first quarter ended March 31, 2023.

SAB Biotherapeutics today announced the U.S. Food and Drug Administration has approved five of seven sections required for the Company’s pending New Animal Drug Application (NADA) for the company’s antibody-generating platform in Transchromosomic (Tc) bovine.

Vicinitas Therapeutics today announced that Christian Hofmann, Ph.D., has been appointed as the company’s Chief Executive Officer and member of the board of directors.

GE HealthCare, a leading global precision care innovator, has named James “Jay” Saccaro as vice president and chief financial officer, succeeding Helmut Zodl who is remaining with the Company to lead special projects regarding separation from GE.